(Q39817471)

14 September 2017

Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon (English)

1 reference

14 September 2017

Monto AS

1

1 reference

14 September 2017

Albrecht JK

series ordinal

2

1 reference

14 September 2017

Schwartz SA

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

32

1 reference

14 September 2017

1

1 reference

14 September 2017

47-50

1 reference

Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

Role of viruses and bacteria in acute wheezy bronchitis in childhood: a study of sputum

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

Rhinovirus and influenza type A infections as precipitants of asthma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

Prevention of Russian Influenza by Amantadine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

Statistical Procedures for Estimating the Community Probability of Illness in Family Studies: Rhinovirus and Influenza

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

A model for obtaining predictable natural transmission of rhinoviruses in human volunteers.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

Inhibition of respiratory virus infection by locally applied interferon

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

INOCULATION OF VOLUNTEERS WITH H RHINOVIRUSES.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172096

Prophylactic efficacy and tolerance of low-dose intranasal interferon-alpha 2 in natural respiratory viral infections

20 August 2018

1 reference

12 December 2020

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

1 reference

12 December 2020

Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection

1 reference

12 December 2020

Prevention of experimental coronavirus colds with intranasal alpha-2b interferon

1 reference

12 December 2020

Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases

1 reference

12 December 2020

Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli

1 reference

12 December 2020

Intranasal Interferon 2 for Prevention of Rhinovirus Infection and Illness

1 reference

12 December 2020

Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.32.1.47

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

2831814

1 reference